Thymosin B15

PEPTIDES

Product Details

CAT No.# CS-BA-00008
Category Peptides
CAS 184973-08-8
Molecular Weight 5172.65
Molecular Formula C220H361N61O82
Purity: >98%
Synonyms: H- Ser-Asp-Lys-Pro-Asp-Leu-Ser-Glu-Val-Glu-Thr-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Asn-Thr-Glu-Glu-Lys-Asn-Thr-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Gln-Gln-Glu-Lys-Glu-Tyr-Asn-Gln-Arg-Ser-OH; seryl-α-aspartyllysylprolyl-α-aspartylleucylseryl-α-glutamylvalyl-α-glutamylthreonylphenylalanyl-α-aspartyllysylseryllysylleucyllysyllysylthreonylasparagylthreonyl-α-glutamyl-α-glutamyllysylasparagylthreonylleucylprolylseryllysyl-α-glutamylthreonylisoleucylglutamylglutamyl-α-glutamyllysyl-α-glutamyltyrosylasparagylglutamylarginylserine
Application Notes: Thymosin B15 levels are elevated in human prostate cancer and correlate positively with the Gleason tumor grade. Thymosin B15 is a potential new biochemical marker for human prostate cancer progression.
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
7. BISPHENOL AF (RING-13C12)
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline




This page contains information about Thymosin B15 Cas 184973-08-8 and its Peptides.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."